StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.92−0.06 (-6.62%)

Close on Nov 18, 2026Market cap $11.30MP/E –Yield –

Pluri net income

Net income is the profit left for shareholders after every expense, interest and tax.

Pluri's net income for the twelve months ending Jun 30, 2026 was -$23.82M. For fiscal 2026 it was -$23.82M. The highest annual figure on record is -$7.45M in fiscal 2010.

Annual net income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$23.82M–
FY2025Jun 30, 2025-$22.58M–
FY2024Jun 30, 2024-$20.89M–
FY2023Jun 30, 2023-$28.32M–
FY2022Jun 30, 2022-$41.24M–
FY2021Jun 30, 2021-$49.87M–
FY2020Jun 30, 2020-$29.15M–
FY2019Jun 30, 2019-$35.31M–
FY2018Jun 30, 2018-$26.13M–
FY2017Jun 30, 2017-$27.81M–
FY2016Jun 30, 2016-$23.25M–
FY2015Jun 30, 2015-$24.68M–
FY2014Jun 30, 2014-$26.93M–
FY2013Jun 30, 2013-$21.16M–
FY2012Jun 30, 2012-$14.79M–
FY2011Jun 30, 2011-$10.85M–
FY2010Jun 30, 2010-$7.45M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$5.88M–
Q3 FY2026CQ1 2026Mar 31, 2026-$5.55M–
Q2 FY2026CQ4 2025Dec 31, 2025-$6.54M–
Q1 FY2026CQ3 2025Sep 30, 2025-$5.85M–
Q4 FY2025CQ2 2025Jun 30, 2025-$7.60M–
Q3 FY2025CQ1 2025Mar 31, 2025-$6.15M–
Q2 FY2025CQ4 2024Dec 31, 2024-$2.96M–
Q1 FY2025CQ3 2024Sep 30, 2024-$5.88M–
Q4 FY2024CQ2 2024Jun 30, 2024-$5.73M–
Q3 FY2024CQ1 2024Mar 31, 2024-$5.29M–
Q2 FY2024CQ4 2023Dec 31, 2023-$4.91M–
Q1 FY2024CQ3 2023Sep 30, 2023-$4.96M–
Q4 FY2023CQ2 2023Jun 30, 2023-$6.46M–
Q3 FY2023CQ1 2023Mar 31, 2023-$7.62M–
Q2 FY2023CQ4 2022Dec 31, 2022-$8.12M–
Q1 FY2023CQ3 2022Sep 30, 2022-$6.12M–
Q4 FY2022CQ2 2022Jun 30, 2022-$9.01M–
Q3 FY2022CQ1 2022Mar 31, 2022-$9.87M–
Q2 FY2022CQ4 2021Dec 31, 2021-$10.94M–
Q1 FY2022CQ3 2021Sep 30, 2021-$11.43M–
Q4 FY2021CQ2 2021Jun 30, 2021-$14.57M–
Q3 FY2021CQ1 2021Mar 31, 2021-$14.25M–
Q2 FY2021CQ4 2020Dec 31, 2020-$12.55M–
Q1 FY2021CQ3 2020Sep 30, 2020-$8.49M–
Q4 FY2020CQ2 2020Jun 30, 2020-$8.14M–
Q3 FY2020CQ1 2020Mar 31, 2020-$7.51M–
Q2 FY2020CQ4 2019Dec 31, 2019-$6.37M–
Q1 FY2020CQ3 2019Sep 30, 2019-$7.14M–
Q4 FY2019CQ2 2019Jun 30, 2019-$7.76M–
Q3 FY2019CQ1 2019Mar 31, 2019-$10.08M–
Q2 FY2019CQ4 2018Dec 31, 2018-$8.68M–
Q1 FY2019CQ3 2018Sep 30, 2018-$8.79M–
Q4 FY2018CQ2 2018Jun 30, 2018-$8.98M–
Q3 FY2018CQ1 2018Mar 31, 2018-$1.53M–
Q2 FY2018CQ4 2017Dec 31, 2017-$8.23M–
Q1 FY2018CQ3 2017Sep 30, 2017-$7.39M–
Q4 FY2017CQ2 2017Jun 30, 2017-$7.02M–
Q3 FY2017CQ1 2017Mar 31, 2017-$7.86M–
Q2 FY2017CQ4 2016Dec 31, 2016-$6.61M–
Q1 FY2017CQ3 2016Sep 30, 2016-$6.32M–

More Pluri figures

See a number that looks wrong?